1097 related articles for article (PubMed ID: 10022625)
1. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
[TBL] [Abstract][Full Text] [Related]
2. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
[TBL] [Abstract][Full Text] [Related]
3. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
[TBL] [Abstract][Full Text] [Related]
4. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
Hoogenraad TU
Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
[TBL] [Abstract][Full Text] [Related]
5. Iron accumulation in the liver of male patients with Wilson's disease.
Shiono Y; Wakusawa S; Hayashi H; Takikawa T; Yano M; Okada T; Mabuchi H; Kono S; Miyajima H
Am J Gastroenterol; 2001 Nov; 96(11):3147-51. PubMed ID: 11721763
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Wilson's disease with zinc: X. Intestinal metallothionein induction.
Yuzbasiyan-Gurkan V; Grider A; Nostrant T; Cousins RJ; Brewer GJ
J Lab Clin Med; 1992 Sep; 120(3):380-6. PubMed ID: 1517684
[TBL] [Abstract][Full Text] [Related]
7. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
Sinha S; Taly AB
J Neurol Sci; 2008 Jan; 264(1-2):129-32. PubMed ID: 17765927
[TBL] [Abstract][Full Text] [Related]
8. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
9. [Copper level and metallothionein-like Cu-binding protein in cultured skin fibroblasts from patients with Menkes' disease and Wilson's disease].
Sato M; Hayashi A; Ito H; Tojo M; Arima M
No To Shinkei; 1984 Nov; 36(11):1063-8. PubMed ID: 6525319
[TBL] [Abstract][Full Text] [Related]
10. The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilson's disease and arthritis therapy.
McQuaid A; Lamand M; Mason J
J Lab Clin Med; 1992 Jun; 119(6):744-50. PubMed ID: 1593220
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis.
Brewer GJ; Dick RD; Yuzbasiyan-Gurkan V; Johnson V; Wang Y
J Lab Clin Med; 1994 Jun; 123(6):849-58. PubMed ID: 8201263
[TBL] [Abstract][Full Text] [Related]
12. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of Wilson's disease: results of a single center experience.
Medici V; Trevisan CP; D'Incà R; Barollo M; Zancan L; Fagiuoli S; Martines D; Irato P; Sturniolo GC
J Clin Gastroenterol; 2006; 40(10):936-41. PubMed ID: 17063115
[TBL] [Abstract][Full Text] [Related]
14. Zinc therapy in Wilson's disease: observations in five patients.
Rossaro L; Sturniolo GC; Giacon G; Montino MC; Lecis PE; Schade RR; Corazza GR; Trevisan C; Naccarato R
Am J Gastroenterol; 1990 Jun; 85(6):665-8. PubMed ID: 2353684
[TBL] [Abstract][Full Text] [Related]
15. Results of treatment of Wilson's disease--own observations.
Jabłońska-Kaszewska I; Drobińska-Jurowiecka A; Dabrowska E; Trocha H
Med Sci Monit; 2003 Aug; 9 Suppl 3():9-14. PubMed ID: 15156603
[TBL] [Abstract][Full Text] [Related]
16. Practical recommendations and new therapies for Wilson's disease.
Brewer GJ
Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
[TBL] [Abstract][Full Text] [Related]
17. [Acute recurrent hemolytic anemia as the first manifestation of Wilson's disease: Report of a case].
El Khattabi A; Seddik H; Fatihi J; Salaheddine H; Badaoui M; Amézyane T; Mahassine F; Ohayon V
Transfus Clin Biol; 2009 Mar; 16(1):39-42. PubMed ID: 19329346
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Wilson's disease with zinc. VI. Initial treatment studies.
Brewer GJ; Yuzbasiyan-Gurkan V; Lee DY; Appelman H
J Lab Clin Med; 1989 Dec; 114(6):633-8. PubMed ID: 2592853
[TBL] [Abstract][Full Text] [Related]
19. Hepatic copper and metallothionein distribution in Wilson's disease (hepatolenticular degeneration).
Nartey NO; Frei JV; Cherian MG
Lab Invest; 1987 Oct; 57(4):397-401. PubMed ID: 3312808
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Wilson's disease with zinc: III. Prevention of reaccumulation of hepatic copper.
Brewer GJ; Hill GM; Dick RD; Nostrant TT; Sams JS; Wells JJ; Prasad AS
J Lab Clin Med; 1987 May; 109(5):526-31. PubMed ID: 3572199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
